People | April 29, 2023
Atul appoints Rangaswamy Iyer as Independent Director
The appointment is effective from May 01, 2023 for five years
The appointment is effective from May 01, 2023 for five years
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Ministry of Ayush is leading a topic group on traditional medicine as part of Focus Group on Artificial Intelligence for Health (FG-AI4H)
Subscribe To Our Newsletter & Stay Updated
